Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 16 points (0.1%) at 16,733 as of Monday, June 2, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,394 issues advancing vs. 1,564 declining with 187 unchanged. The Health Services industry currently sits down 0.7% versus the S&P 500, which is unchanged. A company within the industry that increased today was DaVita HealthCare Partners ( DVA), up 0.9%. On the negative front, top decliners within the industry include Grifols ( GRFS), down 2.5%, Covidien ( COV), down 0.8% and Abbott Laboratories ( ABT), down 0.6%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Cigna ( CI) is one of the companies pushing the Health Services industry higher today. As of noon trading, Cigna is up $0.69 (0.8%) to $90.47 on light volume. Thus far, 689,528 shares of Cigna exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $89.64-$90.50 after having opened the day at $90.13 as compared to the previous trading day's close of $89.78. Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $24.2 billion and is part of the health care sector. Shares are up 2.6% year-to-date as of the close of trading on Friday. Currently there are 8 analysts who rate Cigna a buy, no analysts rate it a sell, and 7 rate it a hold. TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.